Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older
2019 ◽
Vol 179
(3)
◽
pp. 687-697
2014 ◽
Vol 8
(8)
◽
pp. 1679-1689
◽
2015 ◽
Vol 22
(6)
◽
pp. 2034-2039
◽
2017 ◽
Vol 59
(2)
◽
pp. 197-203
◽
2015 ◽